Martha Bhattacharya
- Associate Professor, Neuroscience
- Associate Professor, BIO5 Institute
- Associate Professor, Neuroscience - GIDP
- Member of the Graduate Faculty
- (520) 626-3321
- Gould-Simpson, Rm. 611
- Tucson, AZ 85721
- marthab1@arizona.edu
Biography
My work investigates the molecular mechanisms of axon and nerve terminal degeneration, a molecular program triggered by toxic, metabolic, or traumatic stress to distal compartments of neurons. I use both Drosophila melanogaster and mouse tools to ask questions about genes involved in axon degeneration and to place these genes in the context of pathways required for axon and synapse maintenance in the face of insults. I have discovered many axon degeneration mediators, including MORN4 and TMEM184b as well as others, and am currently following up on their roles within neurons during normal neuronal functioning and in the context of neurodegenerative disorders such as ALS and Alzheimer’s Disease. Within these scientific pursuits, I have mentored a total of 9 undergraduate students, 3 first-year PhD students, and three technicians.
To my lab I bring extensive experience with imaging, including calcium imaging, fixed tissue confocal imaging, electron microscopy, and live imaging of axon transport. In addition, I have developed or utilized many imaging analysis tools to investigate sensory neuron behavior, axon injury and degeneration. I have 10 years of experience with genetics and epistasis analysis in Drosophila melanogaster, having completed a screen in this system as well as designed and created mutant flies using Cas9/CRISPR-based gene editing. I also have 18 years of experience with mice, including in vivo nerve injuries, toluidine blue nerve staining and analysis, behavior, and primary cell culture methods. I also bring 20 years of experience with molecular biology and molecular genetics techniques, including qPCR, RNAseq, plasmid design and transgenic organism creation in both fly and mouse systems. My lab combines all of these techniques to answer questions about axon and nerve terminal degeneration pathways in ways that give clear results while enabling in-house translation of mechanisms from flies to mammals.
Degrees
- Ph.D. Cell Biology
- University of California, San Francisco, San Francisco, California, United States
- The Cellular Basis of Mechanotransduction in Mouse Sensory Neurons
- B.A. Biochemical Sciences
- Harvard University, Cambridge, Massachusetts, United States
Work Experience
- St. Louis College of Pharmacy (2014 - 2016)
- Washington University in St. Louis, St. Louis, Missouri (2008 - 2014)
- San Francisco State University, San Francisco, California (2006 - 2008)
- Phillips Andover Academy (2000 - 2001)
Awards
- Margaret Briehl and Dennis Ray Five Star Faculty Award
- Franke Honors College and University of Arizona, Spring 2022
- College of Science/ Herbst Endowment Dean's Innovation and Education Award
- College of Science, Winter 2021
- College of Science, Winter 2020
- College of Science Early-Career Outstanding Teaching Award
- College of Science, Fall 2021
Interests
No activities entered.
Courses
2024-25 Courses
-
Directed Research
NROS 492 (Spring 2025) -
Dissertation
NRSC 920 (Spring 2025) -
Dissertation
PCOL 920 (Spring 2025) -
Neuroscience Colloquium
NRSC 695F (Spring 2025) -
Neuroscience Colloquium
NRSC 695G (Spring 2025) -
Preceptorship
NROS 491 (Spring 2025) -
Research
GENE 900 (Spring 2025) -
Research
PHSC 900 (Spring 2025) -
Research Conference
PCOL 695A (Spring 2025) -
VIP-CURE: Brain Communication
NROS 397 (Spring 2025) -
Dissertation
NRSC 920 (Fall 2024) -
Dissertation
PCOL 920 (Fall 2024) -
Honors Directed Research
NROS 392H (Fall 2024) -
Research Conference
PCOL 695A (Fall 2024)
2023-24 Courses
-
Directed Research
NROS 392 (Spring 2024) -
Dissertation
NRSC 920 (Spring 2024) -
Dissertation
PCOL 920 (Spring 2024) -
Honors Directed Research
NROS 392H (Spring 2024) -
Honors Thesis
NROS 498H (Spring 2024) -
Methods In Neuroscience
NRSC 700 (Spring 2024) -
Research
NRSC 900 (Spring 2024) -
Research Conference
PCOL 695A (Spring 2024) -
Senior Capstone
NROS 498 (Spring 2024) -
VIP-CURE: Brain Communication
NROS 397 (Spring 2024) -
Directed Research
NROS 392 (Fall 2023) -
Dissertation
NRSC 920 (Fall 2023) -
Dissertation
PCOL 920 (Fall 2023) -
Honors Directed Research
NROS 392H (Fall 2023) -
Honors Thesis
NROS 498H (Fall 2023) -
Lab Research Rotation
GENE 792 (Fall 2023) -
Mechanisms of Neural Dev.
NROS 440 (Fall 2023) -
Methods In Neuroscience
NRSC 700 (Fall 2023) -
Preceptorship
NROS 491 (Fall 2023) -
Research
NRSC 900 (Fall 2023) -
Research Conference
PCOL 695A (Fall 2023) -
Scientific Writing
IMB 575 (Fall 2023) -
Scientific Writing
NRSC 575 (Fall 2023) -
VIP-CURE: Brain Communication
NSCS 397 (Fall 2023)
2022-23 Courses
-
Directed Research
MCB 792 (Spring 2023) -
Dissertation
NRSC 920 (Spring 2023) -
Honors Thesis
NSCS 498H (Spring 2023) -
Preceptorship
NSCS 491 (Spring 2023) -
VIP-CURE: Brain Communication
NSCS 397 (Spring 2023) -
Directed Research
NROS 392 (Fall 2022) -
Dissertation
NRSC 920 (Fall 2022) -
Honors Thesis
NSCS 498H (Fall 2022) -
Methods In Neuroscience
NRSC 700 (Fall 2022)
2021-22 Courses
-
Honors Directed Research
NSCS 392H (Spring 2022) -
Independent Study
NSCS 399 (Spring 2022) -
Lab Research Rotation
GENE 792 (Spring 2022) -
Mechanisms of Neural Dev.
NSCS 440 (Spring 2022) -
Methods In Neuroscience
NRSC 700 (Spring 2022) -
Preceptorship
NSCS 491 (Spring 2022) -
Research
NRSC 900 (Spring 2022) -
VIP-CURE: Brain Communication
NSCS 397 (Spring 2022) -
Directed Research
NSCS 392 (Fall 2021) -
Dissertation
NRSC 920 (Fall 2021) -
Honors Directed Research
NSCS 392H (Fall 2021) -
Research
NRSC 900 (Fall 2021)
2020-21 Courses
-
Directed Research
BIOC 392 (Spring 2021) -
Directed Research
NSCS 392 (Spring 2021) -
Directed Research
NSCS 492 (Spring 2021) -
Directed Rsrch
MCB 392 (Spring 2021) -
Dissertation
NRSC 920 (Spring 2021) -
Mechanisms of Neural Dev.
NSCS 440 (Spring 2021) -
Methods In Neuroscience
NRSC 700 (Spring 2021) -
Research
NRSC 900 (Spring 2021) -
Directed Research
NSCS 492 (Fall 2020) -
Dissertation
NRSC 920 (Fall 2020) -
Honors Thesis
NSCS 498H (Fall 2020) -
Research
NRSC 900 (Fall 2020)
2019-20 Courses
-
Directed Research
MCB 792 (Spring 2020) -
Dissertation
NRSC 920 (Spring 2020) -
Honors Independent Study
NSCS 499H (Spring 2020) -
Honors Preceptorship
NSCS 491H (Spring 2020) -
Honors Thesis
NSCS 498H (Spring 2020) -
Mechanisms of Neural Dev.
NSCS 440 (Spring 2020) -
Methods In Neuroscience
NRSC 700 (Spring 2020) -
Preceptorship
NSCS 491 (Spring 2020) -
Dissertation
NRSC 920 (Fall 2019) -
Honors Thesis
NSCS 498H (Fall 2019) -
Methods In Neuroscience
NRSC 700 (Fall 2019)
2018-19 Courses
-
Honors Independent Study
BIOC 299H (Spring 2019) -
Introduction to Research
MCB 795A (Spring 2019) -
Mechanisms of Neural Dev.
NSCS 440 (Spring 2019) -
Research
NRSC 900 (Spring 2019) -
Introduction to Research
MCB 795A (Fall 2018) -
Methods In Neuroscience
NRSC 700 (Fall 2018)
2017-18 Courses
-
Honors Independent Study
NSCS 399H (Spring 2018) -
Methods In Neuroscience
NRSC 700 (Spring 2018) -
Directed Research
NSCS 492 (Fall 2017) -
Honors Independent Study
MCB 399H (Fall 2017)
Scholarly Contributions
Journals/Publications
- Bhattacharya, M. R. (2023). A nerve-wracking buzz: lessons from models of peripheral neuropathy and axon degeneration. Frontiers in aging neuroscience, 15, 1166146.More infoThe degeneration of axons and their terminals occurs following traumatic, toxic, or genetically-induced insults. Common molecular mechanisms unite these disparate triggers to execute a conserved nerve degeneration cascade. In this review, we will discuss how models of peripheral nerve injury and neuropathy in have led the way in advancing molecular understanding of axon degeneration and nerve injury pathways. Both neuron-intrinsic as well as glial responses to injury will be highlighted. Finally, we will offer perspective on what additional questions should be answered to advance these discoveries toward clinical interventions for patients with neuropathy.
- Wright, E. B., Larsen, E. G., Coloma-Roessle, C. M., Hart, H. R., & Bhattacharya, M. R. (2023). Transmembrane protein 184B (TMEM184B) promotes expression of synaptic gene networks in the mouse hippocampus. BMC genomics, 24(1), 559.More infoIn Alzheimer's Disease (AD) and other dementias, hippocampal synaptic dysfunction and loss contribute to the progression of memory impairment. Recent analysis of human AD transcriptomes has provided a list of gene candidates that may serve as drivers of disease. One such candidate is the membrane protein TMEM184B. To evaluate whether TMEM184B contributes to neurological impairment, we asked whether loss of TMEM184B in mice causes gene expression or behavior alterations, focusing on the hippocampus. Because one major risk factor for AD is age, we compared young adult (5-month-old) and aged (15-month-old) wild type and Tmem184b-mutant mice to assess the dual contributions of age and genotype. TMEM184B loss altered expression of pre- and post-synaptic transcripts by 5 months and continued through 15 months, specifically affecting genes involved in synapse assembly and neural development. Wnt-activated enhancer elements were enriched among differentially expressed genes, suggesting an intersection with this pathway. Few differences existed between young adult and aged mutants, suggesting that transcriptional effects of TMEM184B loss are relatively constant. To understand how TMEM184B disruption may impact behaviors, we evaluated memory using the novel object recognition test and anxiety using the elevated plus maze. Young adult Tmem184b-mutant mice show normal object discrimination, suggesting a lack of memory impairment at this age. However, mutant mice showed decreased anxiety, a phenotype seen in some neurodevelopmental disorders. Taken together, our data suggest that TMEM184B is required for proper synaptic gene expression and anxiety-related behavior and is more likely to be linked to neurodevelopmental disorders than to dementia.
- Cho, T. S., Beigaitė, E., Klein, N. E., Sweeney, S. T., & Bhattacharya, M. R. (2022). The Putative Drosophila TMEM184B Ortholog Tmep Ensures Proper Locomotion by Restraining Ectopic Firing at the Neuromuscular Junction. Molecular neurobiology, 59(4), 2605-2619.More infoTMEM184B is a putative seven-pass membrane protein that promotes axon degeneration after injury. TMEM184B mutation causes aberrant neuromuscular architecture and sensory and motor behavioral defects in mice. The mechanism through which TMEM184B causes neuromuscular defects is unknown. We employed Drosophila melanogaster to investigate the function of the closely related gene, Tmep (CG12004), at the neuromuscular junction. We show that Tmep is required for full adult viability and efficient larval locomotion. Tmep mutant larvae have a reduced body contraction rate compared to controls, with stronger deficits in females. In recordings from body wall muscles, Tmep mutants show substantial hyperexcitability, with many postsynaptic potentials fired in response to a single stimulation, consistent with a role for Tmep in restraining synaptic excitability. Additional branches and satellite boutons at Tmep mutant neuromuscular junctions are consistent with an activity-dependent synaptic overgrowth. Tmep is expressed in endosomes and synaptic vesicles within motor neurons, suggesting a possible role in synaptic membrane trafficking. Using RNAi knockdown, we show that Tmep is required in motor neurons for proper larval locomotion and excitability, and that its reduction increases levels of presynaptic calcium. Locomotor defects can be rescued by presynaptic knockdown of endoplasmic reticulum calcium channels or by reducing evoked release probability, further suggesting that excess synaptic activity drives behavioral deficiencies. Our work establishes a critical function for Tmep in the regulation of synaptic transmission and locomotor behavior.
- Larsen, E. G., Cho, T. S., McBride, M. L., Feng, J., Manivannan, B., Madura, C., Klein, N. E., Wright, E. B., Wickstead, E. S., Garcia-Verdugo, H. D., Jarvis, C., Khanna, R., Hu, H., Largent-Milnes, T. M., & Bhattacharya, M. R. (2022). Transmembrane protein TMEM184B is necessary for interleukin-31-induced itch. Pain, 163(5), e642-e653.More infoNociceptive and pruriceptive neurons in the dorsal root ganglia (DRG) convey sensations of pain and itch to the spinal cord, respectively. One subtype of mature DRG neurons, comprising 6% to 8% of neurons in the ganglia, is responsible for sensing mediators of acute itch and atopic dermatitis, including the cytokine IL-31. How itch-sensitive (pruriceptive) neurons are specified is unclear. Here, we show that transmembrane protein 184B (TMEM184B), a protein with roles in axon degeneration and nerve terminal maintenance, is required for the expression of a large cohort of itch receptors, including those for interleukin 31 (IL-31), leukotriene C4, and histamine. Male and female mice lacking TMEM184B show reduced responses to IL-31 but maintain normal responses to pain and mechanical force, indicating a specific behavioral defect in IL-31-induced pruriception. Calcium imaging experiments indicate that a reduction in IL-31-induced calcium entry is a likely contributor to this phenotype. We identified an early failure of proper Wnt-dependent transcriptional signatures and signaling components in Tmem184b mutant mice that may explain the improper DRG neuronal subtype specification. Accordingly, lentiviral re-expression of TMEM184B in mutant embryonic neurons restores Wnt signatures. Together, these data demonstrate that TMEM184B promotes adult somatosensation through developmental Wnt signaling and promotion of proper pruriceptive gene expression. Our data illuminate a new key regulatory step in the processes controlling the establishment of diversity in the somatosensory system.
- Bhattacharya, M. R. (2020). A Chemotherapy-Induced Peripheral Neuropathy Model in Drosophila melanogaster. Methods in molecular biology (Clifton, N.J.), 2143, 301-310.More infoPeripheral neuropathies are one of the largest categories of neurodegenerative diseases. To investigate their mechanisms, many in vitro and in vivo models can be employed. Here we present a protocol for the induction of chemotherapy-induced peripheral neuropathy (CIPN) in the Drosophila melanogaster (fruit fly) model system. Using a clinically relevant degeneration initiator, paclitaxel (taxol), it is possible to model many aspects of axon and dendrite degeneration while in a genetically tractable, in vivo system. In this protocol, we feed larval stage Drosophila neurotoxic chemotherapy drugs during the duration of larval development, followed by dissection and imaging of genetically labeled sensory axons and dendrites. Both axons and dendrites degenerate with taxol exposure. Our protocol should facilitate the adoption and expansion of this model to include other neurotoxic compounds.
- Bhattacharya, M. R., Geisler, S., Pittman, S. K., Doan, R. A., Weihl, C. C., Milbrandt, J., & DiAntonio, A. (2016). TMEM184b Promotes Axon Degeneration and Neuromuscular Junction Maintenance. The Journal of neuroscience : the official journal of the Society for Neuroscience, 36(17), 4681-9.More infoComplex nervous systems achieve proper connectivity during development and must maintain these connections throughout life. The processes of axon and synaptic maintenance and axon degeneration after injury are jointly controlled by a number of proteins within neurons, including ubiquitin ligases and mitogen activated protein kinases. However, our understanding of these molecular cascades is incomplete. Here we describe the phenotype resulting from mutation of TMEM184b, a protein identified in a screen for axon degeneration mediators. TMEM184b is highly expressed in the mouse nervous system and is found in recycling endosomes in neuronal cell bodies and axons. Disruption of TMEM184b expression results in prolonged maintenance of peripheral axons following nerve injury, demonstrating a role for TMEM184b in axon degeneration. In contrast to this protective phenotype in axons, uninjured mutant mice have anatomical and functional impairments in the peripheral nervous system. Loss of TMEM184b causes swellings at neuromuscular junctions that become more numerous with age, demonstrating that TMEM184b is critical for the maintenance of synaptic architecture. These swellings contain abnormal multivesicular structures similar to those seen in patients with neurodegenerative disorders. Mutant animals also show abnormal sensory terminal morphology. TMEM184b mutant animals are deficient on the inverted screen test, illustrating a role for TMEM184b in sensory-motor function. Overall, we have identified an important function for TMEM184b in peripheral nerve terminal structure, function, and the axon degeneration pathway.
- Bhattacharya, M. R., Gerdts, J., Naylor, S. A., Royse, E. X., Ebstein, S. Y., Sasaki, Y., Milbrandt, J., & DiAntonio, A. (2012). A model of toxic neuropathy in Drosophila reveals a role for MORN4 in promoting axonal degeneration. The Journal of neuroscience : the official journal of the Society for Neuroscience, 32(15), 5054-61.More infoAxonal degeneration is a molecular self-destruction cascade initiated following traumatic, toxic, and metabolic insults. Its mechanism underlies a number of disorders including hereditary and diabetic neuropathies and the neurotoxic side effects of chemotherapy drugs. Molecules that promote axonal degeneration could represent potential targets for therapy. To identify such molecules, we designed a screening platform based on intoxication of Drosophila larvae with paclitaxel (taxol), a chemotherapeutic agent that causes neuropathy in cancer patients. In Drosophila, taxol treatment causes swelling, fragmentation, and loss of axons in larval peripheral nerves. This axonal loss is not due to apoptosis of neurons. Taxol-induced axonal degeneration in Drosophila shares molecular execution mechanisms with vertebrates, including inhibition by both NMNAT (nicotinamide mononucleotide adenylyltransferase) expression and loss of wallenda/DLK (dual leucine zipper kinase). In a pilot RNAi-based screen we found that knockdown of retinophilin (rtp), which encodes a MORN (membrane occupation and recognition nexus) repeat-containing protein, protects axons from degeneration in the presence of taxol. Loss-of-function mutants of rtp replicate this axonal protection. Knockdown of rtp also delays axonal degeneration in severed olfactory axons. We demonstrate that the mouse ortholog of rtp, MORN4, promotes axonal degeneration in mouse sensory axons following axotomy, illustrating conservation of function. Hence, this new model can identify evolutionarily conserved genes that promote axonal degeneration, and so could identify candidate therapeutic targets for a wide-range of axonopathies.
- Bhattacharya, M. R., Bautista, D. M., Wu, K., Haeberle, H., Lumpkin, E. A., & Julius, D. (2008). Radial stretch reveals distinct populations of mechanosensitive mammalian somatosensory neurons. Proceedings of the National Academy of Sciences of the United States of America, 105(50), 20015-20.More infoPrimary afferent somatosensory neurons mediate our sense of touch in response to changes in ambient pressure. Molecules that detect and transduce thermal stimuli have been recently identified, but mechanisms underlying mechanosensation, particularly in vertebrate organisms, remain enigmatic. Traditionally, mechanically evoked responses in somatosensory neurons have been assessed one cell at a time by recording membrane currents in response to application of focal pressure, suction, or osmotic challenge. Here, we used radial stretch in combination with live-cell calcium imaging to gain a broad overview of mechanosensitive neuronal subpopulations. We found that different stretch intensities activate distinct subsets of sensory neurons as defined by size, molecular markers, or pharmacological attributes. In all subsets, stretch-evoked responses required extracellular calcium, indicating that mechanical force triggers calcium influx. This approach extends the repertoire of stimulus paradigms that can be used to examine mechanotransduction in mammalian sensory neurons, facilitating future physiological and pharmacological studies.
- Li, R., Chase, M., Jung, S. K., Smith, P. J., & Loeken, M. R. (2005). Hypoxic stress in diabetic pregnancy contributes to impaired embryo gene expression and defective development by inducing oxidative stress. American journal of physiology. Endocrinology and metabolism, 289(4), E591-9.More infoWe have shown that neural tube defects (NTD) in a mouse model of diabetic embryopathy are associated with deficient expression of Pax3, a gene required for neural tube closure. Hyperglycemia-induced oxidative stress is responsible. Before organogenesis, the avascular embryo is physiologically hypoxic (2-5% O(2)). Here we hypothesized that, because O(2) delivery is limited at this stage of development, excess glucose metabolism could accelerate the rate of O(2) consumption, thereby exacerbating the hypoxic state. Because hypoxia can increase mitochondrial superoxide production, excessive hypoxia may contribute to oxidative stress. To test this, we assayed O(2) flux, an indicator of O(2) availability, in embryos of glucose-injected hyperglycemic or saline-injected mice. O(2) flux was reduced by 30% in embryos of hyperglycemic mice. To test whether hypoxia replicates, and hyperoxia suppresses, the effects of maternal hyperglycemia, pregnant mice were housed in controlled O(2) chambers on embryonic day 7.5. Housing pregnant mice in 12% O(2), or induction of maternal hyperglycemia (>250 mg/dl), decreased Pax3 expression fivefold, and increased NTD eightfold. Conversely, housing pregnant diabetic mice in 30% O(2) significantly suppressed the effect of maternal diabetes to increase NTD. These effects of hypoxia appear to be the result of increased production of mitochondrial superoxide, as indicated by assay of lipid peroxidation, reduced glutathione, and H(2)O(2). Further support of this interpretation was the effect of antioxidants, which blocked the effects of maternal hypoxia, as well as hyperglycemia, on Pax3 expression and NTD. These observations suggest that maternal hyperglycemia depletes O(2) in the embryo and that this contributes to oxidative stress and the adverse effects of maternal hyperglycemia on embryo development.